SHILPAMED.NS
Shilpa Medicare Ltd
Price:  
694.90 
INR
Volume:  
219,407.00
India | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SHILPAMED.NS WACC - Weighted Average Cost of Capital

The WACC of Shilpa Medicare Ltd (SHILPAMED.NS) is 15.4%.

The Cost of Equity of Shilpa Medicare Ltd (SHILPAMED.NS) is 16.75%.
The Cost of Debt of Shilpa Medicare Ltd (SHILPAMED.NS) is 9.05%.

Range Selected
Cost of equity 15.30% - 18.20% 16.75%
Tax rate 22.70% - 31.30% 27.00%
Cost of debt 7.60% - 10.50% 9.05%
WACC 14.0% - 16.7% 15.4%
WACC

SHILPAMED.NS WACC calculation

Category Low High
Long-term bond rate 6.9% 7.4%
Equity market risk premium 8.3% 9.3%
Adjusted beta 1.01 1.11
Additional risk adjustments 0.0% 0.5%
Cost of equity 15.30% 18.20%
Tax rate 22.70% 31.30%
Debt/Equity ratio 0.15 0.15
Cost of debt 7.60% 10.50%
After-tax WACC 14.0% 16.7%
Selected WACC 15.4%

SHILPAMED.NS's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for SHILPAMED.NS:

cost_of_equity (16.75%) = risk_free_rate (7.15%) + equity_risk_premium (8.80%) * adjusted_beta (1.01) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.